Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.17 (Beat by $0.11) |
EPS GAAP Actual | $1.17 (Beat by $0.11) |
Revenue Actual | $0.5646B |
Revenue Surprise | Beat by $564.6M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.88 |
EPS GAAP Estimate | $0.88 |
Revenue Estimate | $0.50634B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 5.72 | 20.6 | 5.48849 | 5.94954 | 1 |
Dec 2027 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.18 | 0.28 | 0.5646B | 13.14% | 48.88M |
FQ1 2025 (Mar 2025) | 0.76 | 0.07 | 0.4638B | 8.39% | 1.43M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.472B | 5% | 472M |
FQ3 2024 (Sep 2024) | 0.88 | 0.88 | 0.4742B | 5.86% | 474.2M |
FQ2 2024 (Jun 2024) | 1 | 1 | 0.4904B | 9.79% | 490.4M |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 0.4249B | 9.27% | 424.9M |
FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 0.4484B | 12.69% | 448.4M |
FQ3 2023 (Sep 2023) | 0.71 | 0.71 | 0.4464B | 22.4% | 446.4M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.88
Consensus Revenue Estimates
0.50634B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.26 | -- | 1.19111 | 1.30723 | 2 |
FQ3 2027 (Sep 2027) | 1.28 | -- | 1.28 | 1.28 | 2 |
FQ2 2027 (Jun 2027) | 1.3 | -- | 1.3 | 1.3 | 2 |
FQ1 2027 (Mar 2027) | 1.115 | -- | 1.05404 | 1.15679 | 2 |
FQ4 2026 (Dec 2026) | 1.09 | -- | 1.06256 | 1.12237 | 1 |
FQ3 2026 (Sep 2026) | 1.06 | -- | 1.03331 | 1.09148 | 1 |
FQ2 2026 (Jun 2026) | 1.08 | -9.26 | 1.05281 | 1.11207 | 1 |
FQ1 2026 (Mar 2026) | 0.98 | 22.45 | 0.95533 | 1.0091 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.63B | -- | 0.6B | 0.64B | 3 |
FQ3 2027 (Sep 2027) | 0.63B | -- | 0.63B | 0.63B | 3 |
FQ2 2027 (Jun 2027) | 0.63B | -- | 0.63B | 0.63B | 3 |
FQ1 2027 (Mar 2027) | 0.6B | -- | 0.57B | 0.61B | 3 |
FQ4 2026 (Dec 2026) | 0.57B | -- | 0.56B | 0.58B | 2 |
FQ3 2026 (Sep 2026) | 0.56B | -- | 0.55B | 0.57B | 2 |
FQ2 2026 (Jun 2026) | 0.55B | -3.44 | 0.54B | 0.56B | 2 |
FQ1 2026 (Mar 2026) | 0.54B | 13.37 | 0.53B | 0.55B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.9 | 1.18 | 0.28 | 23.73% |
FQ1 2025 (Mar 2025) | 0.69 | 0.76 | 0.07 | 9.21% |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.88 | 0.88 | 100% | |
FQ2 2024 (Jun 2024) | 1 | 1 | 100% | |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
FQ4 2023 (Dec 2023) | 0.76 | 0.76 | 100% | |
FQ3 2023 (Sep 2023) | 0.71 | 0.71 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.52B | $0.56B | $48.88M | 8.66% |
FQ1 2025 (Mar 2025) | $0.46B | $0.46B | $1.43M | 0.31% |
FQ4 2024 (Dec 2024) | $0B | $0.47B | $472M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.47B | $474.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.49B | $490.4M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.42B | $424.9M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.45B | $448.4M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.45B | $446.4M | 100% |